对氧磷酶-1与颈动脉疾病症状状态的关系
本研究纳入74例颈动脉狭窄行内膜剥脱术患者,比较症状性与无症状性患者的对氧磷酶-1(PON-1)水平。结果显示症状组PON-1水平显著更低(5.3 ± 1.19 vs. 4.6 ± 1.36 ng/mL,P = 0.025),ROC曲线下面积为0.654(P = 0.023)。结论认为低PON-1水平与症状状态独立相关。
要点
- 症状性颈动脉狭窄患者PON-1水平显著低于无症状患者。
- PON-1预测症状的ROC曲线下面积为0.654,提示有一定区分能力。
- PON-1与症状的关联独立于其他传统心血管危险因素。
核心结论
- 降低的PON-1水平与颈动脉狭窄患者的症状状态显著相关,且独立于其他传统心血管因素。
研究设计与样本
- 回顾性研究,纳入2012年7月至2014年7月在希腊雅典Laikon医院血管外科行颈动脉内膜剥脱术的所有患者,共74例,其中41例无症状,平均年龄68.5岁。
主要发现
- 症状组PON-1水平为4.6 ± 1.36 ng/mL,无症状组为5.3 ± 1.19 ng/mL,两组差异有统计学意义(P = 0.025)。
- ROC分析显示PON-1预测症状的曲线下面积为0.654(P = 0.023)。
临床怎么用
- PON-1可能作为颈动脉狭窄患者症状状态的潜在生物标志物,但尚需进一步前瞻性研究验证其预测脑血管事件的作用。
局限性
- 研究为回顾性设计,样本量较小(74例),PON-1预测症状的准确性有限(AUC 0.654)。
- 作者指出需要进一步前瞻性研究评估PON-1在预测颈动脉疾病患者脑血管事件中的作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Paraoxonase-1 (PON-1) is a high-density lipoprotein (HDL)-associated hydrolase that appears to have a protective action against atherosclerosis. The aim of our study is to identify whether PON-1 levels may be associated with the manifestation of symptoms in patients with carotid artery stenosis. METHODS: We studied all patients who underwent carotid endarterectomy in the Vascular Surgery Department of Laikon Hospital, Athens, Greece, from July 2012 to July 2014. Medical history was recorded and PON-1 glucose, total cholesterol, HDL cholesterol, low-density lipoprotein cholesterol, and triglycerides levels were measured. Variables were compared between symptomatic and asymptomatic patients. A receiver operating characteristic (ROC) curve was constructed to evaluate the accuracy of PON-1 to predict symptoms. RESULTS: A total of 74 patients were included, 41 were asymptomatic and the mean age was 68.5 years. The 2 groups appear to differ significantly with regards to the PON-1 levels, with the symptomatic group showing lower levels (5.3 ± 1.19 vs. 4.6 ± 1.36 ng/mL; P = 0.025). ROC analysis demonstrated an area under the curve of 0.654 (P = 0.023). CONCLUSIONS: Reduced PON-1 levels showed a significant association with symptomatic status, which was independent of other traditional cardiovascular factors. Further studies are required to prospectively assess the role of PON-1 in predicting cerebrovascular events in patients with carotid artery disease.
引用
- Lioudaki S, Verikokos C, Kouraklis G, et al. Paraoxonase-1 and Symptomatic Status in Carotid Artery Disease. Ann Vasc Surg. 2019. PMID: 31626928. doi:10.1016/j.avsg.2019.07.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。